Skip to main content
Article
Medication assistance programs: do all in need benefit equally
Quantitative Health Sciences Publications and Presentations
  • Maria Pisu, University of Alabama
  • Katie Crenshaw, University of Alabama
  • Ellen M. Funkhouser, University of Alabama
  • Midge N. Ray, University of Alabama at Birmingham
  • Catarina I. Kiefe, University of Massachusetts Medical School
  • Kenneth G. Saag, University of Alabama
  • Cynthia L. LaCivita, ASHP Research and Education Foundation
  • Jeroan J. Allison, University of Massachusetts Medical School
UMMS Affiliation
Department of Quantitative Health Sciences
Date
11-1-2010
Document Type
Article
Medical Subject Headings
African Americans; Aged; Alabama; Cross-Sectional Studies; Drug Industry; Drug Prescriptions; European Continental Ancestry Group; Female; Humans; Logistic Models; Male; Middle Aged; Social Welfare
Abstract

OBJECTIVE: To determine if medication assistance programs (MAPs) provided by pharmaceutical companies were used differently by African Americans and Whites.

RESEARCH DESIGN: A cross-sectional survey was conducted among patients of primary care practices from 2005 to 2007 within the Alabama Nonsteroidal Anti-Inflammatory Drug (NSAID) Patient Safety Study.

SETTING: Telephone survey.

PARTICIPANTS: Respondents were 568 African American and White patients reporting annual household incomes < $50,000.

MAIN OUTCOME MEASURE: Use of MAPs.

RESULTS: Of all patients, 12.8% used MAPs, 39.5% were African American, 75.2% were female, 69.1% were aged > 65 years, 79.8% had annual household incomes < $25,000, and 35.5% indicated that their income was inadequate to meet their basic needs. MAPs were used by 11.2% African-Americans and 14.0% Whites. After multivariable adjustment, MAP use was higher among respondents with incomes not adequate to meet basic needs (odds ratio [OR]: 2.19, 95% confidence interval [CI]: 1.17-4.08) but lower among African Americans than Whites (OR: 0.49, 95% CI: 0.25-0.95). Physician characteristics did not independently predict MAP use.

CONCLUSIONS: Overall MAP use was low even among the most vulnerable, and especially among African Americans. As currently used, MAPs may contribute to disparities in medication access.

Comments

Citation: Ethn Dis. 2010 Autumn;20(4):339-45.

Related Resources
Link to Article in PubMed
Citation Information
Maria Pisu, Katie Crenshaw, Ellen M. Funkhouser, Midge N. Ray, et al.. "Medication assistance programs: do all in need benefit equally" Vol. 20 Iss. 4 (2010) ISSN: 1049-510X (Linking)
Available at: http://works.bepress.com/catarina_kiefe/195/